SomnoMed breaks sales records
Morgans
SomnoMed announced today that in Q4 of FY15 it had broken sales records in all three geographic regions – North America, Europe and APAC/Japan, recording a year on year growth for the quarter of 21.2%. During the three months period sales reached 14,517 units, the highest quarterly unit sales in the history of SomnoMed. Quarterly sales in North America exceeded of 8,000 units; Europe sold over 5,000 units and the combined APAC/Japan region sold over 1,400 units. Revenue is expected to be A$32.5m on unit sales of 51,355 (in line with our forecast). The market will like this update. (SOM, Add, Price Target A$3.23). Here is the link to the blog site: (VIEW LINK)
1 stock mentioned
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise